Drug Trial Radar · NCT00050895
Comparing the Safety, Effectiveness, and Tolerability of Three Anti-HIV Drug Regimens for Treatment-Naive Patients
Last checked: Nov 19, 2026Latest source record: Nov 1, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
775
Actual
Start
Not stated
Primary completion
Not stated
Study completion Mar 2006
Sponsor
- Sponsor type
- NIH
- First posted
- Jan 1, 2003
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 13 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
With new strategies and drugs available, many different regimens exist for the treatment of HIV. The purpose of this study is to compare three different anti-HIV drug regimens as first-time treatments for HIV infection.
Conditions
- HIV Infections
Interventions
Lopinavir/ritonavirDrug
EfavirenzDrug
StavudineDrug
ZidovudineDrug
LamivudineDrug
Tenofovir disoproxil fumarateDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time from study entry to virologic failure
- time from study entry to regimen completion
Locations
60 sites in 2 countries. Site status is shown where the registry gives one.
Alabama Therapeutics CRS
Birmingham, Alabama
USC CRS
Los Angeles, California
UCLA CARE Center CRS
Los Angeles, California
Stanford CRS
Palo Alto, California
UC Davis Medical Center
Sacramento, California
Univ. of California Davis Med. Ctr., ACTU
Sacramento, California
Ucsd, Avrc Crs
San Diego, California
Ucsf Aids Crs
San Francisco, California
Santa Clara Valley Med. Ctr.
San Jose, California
San Mateo County AIDS Program
San Mateo, California
Harbor-UCLA Med. Ctr. CRS
Torrance, California
University of Colorado Hospital CRS
Aurora, Colorado
Georgetown University CRS (GU CRS)
Washington D.C., District of Columbia
Univ. of Miami AIDS CRS
Miami, Florida
The Ponce de Leon Ctr. CRS
Atlanta, Georgia
Univ. of Hawaii at Manoa, Leahi Hosp.
Honolulu, Hawaii
Northwestern University CRS
Chicago, Illinois
Rush Univ. Med. Ctr. ACTG CRS
Chicago, Illinois
Cook County Hosp. CORE Ctr.
Chicago, Illinois
Methodist Hosp. of Indiana
Indianapolis, Indiana
Indiana Univ. School of Medicine, Infectious Disease Research Clinic
Indianapolis, Indiana
Indiana Univ. School of Medicine, Wishard Memorial
Indianapolis, Indiana
Univ. of Iowa Healthcare, Div. of Infectious Diseases
Iowa City, Iowa
IHV Baltimore Treatment CRS
Baltimore, Maryland
Johns Hopkins Adult AIDS CRS
Baltimore, Maryland
Massachusetts General Hospital ACTG CRS
Boston, Massachusetts
Bmc Actg Crs
Boston, Massachusetts
Beth Israel Deaconess Med. Ctr., ACTG CRS
Boston, Massachusetts
Brigham and Women's Hosp. ACTG CRS
Boston, Massachusetts
SSTAR, Family Healthcare Ctr.
Fall River, Massachusetts
University of Minnesota, ACTU
Minneapolis, Minnesota
St. Louis ConnectCare, Infectious Diseases Clinic
St Louis, Missouri
Washington U CRS
St Louis, Missouri
Univ. of Nebraska Med. Ctr., Durham Outpatient Ctr.
Omaha, Nebraska
SUNY - Buffalo, Erie County Medical Ctr.
Buffalo, New York
Beth Israel Med. Ctr., ACTU
New York, New York
NY Univ. HIV/AIDS CRS
New York, New York
Cornell CRS
New York, New York
Columbia Univ., HIV Prevention and Treatment Medical Ctr.
New York, New York
HIV Prevention & Treatment CRS
New York, New York
Showing 40 of 60 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.